Literature DB >> 14520176

Preference among female Army recruits for use of self-administrated vaginal swabs or urine to screen for Chlamydia trachomatis genital infections.

Y-H Hsieh1, M R Howell, J C Gaydos, K T McKee, T C Quinn, C A Gaydos.   

Abstract

BACKGROUND: Use of self-administered vaginal swabs (SAS) for the detection of Chlamydia trachomatis by nucleic acid amplification tests simplifies specimen collection and transport, especially for women in nonclinical settings. GOAL: We investigated the preference and comfort level of military women for the collection of SAS, compared with urine, for the diagnosis of genital chlamydial infections. STUDY
DESIGN: During March through August 1999, female Army recruits in basic training at Fort Jackson, South Carolina, were invited to participate in the study. Participants were requested to complete a questionnaire after providing both first-void urine (FVU) and SAS specimens. Participant characteristics, preferences, and comfort levels were assessed using multivariate logistic regression.
RESULTS: From 4496 eligible female recruits, 1403 (31%) completed questionnaires and 1382 provided both specimens; 11.8% (166 of 1403) of participants were infected with chlamydia. The relative sensitivity and specificity of the C. trachomatis Ligase Chain Reaction test on SAS in 1382 matched pairs was 81.1% and 98.6%, respectively, using the test result on urine specimens as the comparison standard. Most of the participants (90.8%) reported that they felt comfortable collecting the FVU specimen, and 69.6% indicated that they felt comfortable collecting SAS. Either specimen collection type received high acceptability at home and in the field, and more women reported that they would collect FVU than reported they would collect SAS in the future (in the field: FVU: 79.4%, SAS: 68.8%, P <0.001); at home: FVU: 90.9%, SAS: 82.9%, P <0.001). When questioned about ease of use, 60.4% of women reported that urine was the easier method. Preferences for SAS were associated with being white and having had sexual risk behaviors in the past 3 months.
CONCLUSION: A study of preferences for urine versus self-administered vaginal swabs for the detection of C. trachomatis in military women showed that women generally found SAS acceptable. SAS should be a feasible alternative to urine collection in situations in which specimen storage or transport is an issue.

Entities:  

Mesh:

Year:  2003        PMID: 14520176     DOI: 10.1097/01.OLQ.0000079048.11771.46

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  24 in total

1.  Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples.

Authors:  Andrew Hardick; Justin Hardick; Billie Jo Wood; Charlotte Gaydos
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2014-03-14

3.  Clinical evaluation of the BD ProbeTec™ Neisseria gonorrhoeae Qx amplified DNA assay on the BD Viper™ system with XTR™ technology.

Authors:  Barbara Van Der Pol; Stephanie N Taylor; William Lebar; Thomas Davis; Deanna Fuller; Leandro Mena; Paul Fine; Charlotte A Gaydos; David H Martin; Edward W Hook
Journal:  Sex Transm Dis       Date:  2012-02       Impact factor: 2.830

4.  Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies.

Authors:  Claude-Edouard C Michel; Christopher Sonnex; Christopher A Carne; John A White; Jose Paolo V Magbanua; Elpidio Cesar B Nadala; Helen H Lee
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

5.  Comparative effectiveness of two self-collected sample kit distribution systems for chlamydia screening on a university campus.

Authors:  Wiley D Jenkins; Rob Weis; Paula Campbell; Mathilda Barnes; Perry Barnes; Charlotte Gaydos
Journal:  Sex Transm Infect       Date:  2012-03-07       Impact factor: 3.519

6.  Knowledge and testing preferences for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections among female undergraduate students.

Authors:  Erin M Keizur; Claire C Bristow; Yeonsoo Baik; Jeffrey D Klausner
Journal:  J Am Coll Health       Date:  2019-05-29

7.  Chlamydia trachomatis age-specific prevalence in women who used an internet-based self-screening program compared to women who were screened in family planning clinics.

Authors:  Charlotte A Gaydos; Mathilda Barnes; Bulbul Aumakhan; Nicole Quinn; Catherine Wright; Patricia Agreda; Pamela Whittle; Terry Hogan
Journal:  Sex Transm Dis       Date:  2011-02       Impact factor: 2.830

8.  From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections.

Authors:  Marcia M Hobbs; Barbara van der Pol; Patricia Totten; Charlotte A Gaydos; Anna Wald; Terri Warren; Rachel L Winer; Robert L Cook; Carolyn D Deal; M Elizabeth Rogers; Julius Schachter; King K Holmes; David H Martin
Journal:  Sex Transm Dis       Date:  2008-01       Impact factor: 2.830

9.  Improving behaviour in self-testing (IBIS): Study on frequency of use, consequences, information needs and use, and quality of currently available consumer information (protocol).

Authors:  Janaica E J Grispen; Martine H P Ickenroth; Nanne K de Vries; Geert-Jan Dinant; Gaby Ronda; Trudy van der Weijden
Journal:  BMC Public Health       Date:  2010-08-03       Impact factor: 3.295

10.  Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.

Authors:  Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.